What happened (announced measures for AYUSH regulatory oversight and quality)

The Ministry of AYUSH announced steps to promote evidence-based Ayurveda, support international accreditation, and improve exports of Ayurvedic products, including products from Kerala. The announced measures focus on regulatory oversight, third-party quality assessment, and international standardisation that covers Ayurveda and Yoga-related products.

Key measures described by the Government include:

WHO-CoPP facilitation: The Ayush Vertical in the Central Drugs Standard Control Organization (CDSCO) facilitates issuance of the World Health Organization Certificate of Pharmaceutical Product (WHO-CoPP) for eligible AYUSH drugs. Facilitation includes joint inspections with State/Union Territory (UT) licensing authorities and CDSCO.QCI quality marks: The Quality Council of India (QCI) awards the AYUSH Standard Mark and the AYUSH Premium Mark based on third-party assessment of compliance with prescribed national and international quality standards.Ayush Quality Mark Programme (2025): The Ministry of AYUSH launched the Ayush Quality Mark Programme in 2025 to strengthen quality assurance, enhance consumer confidence, and improve global recognition and competitiveness of AYUSH products and services.

Background and earlier position (institutions and quality ecosystem described)

The Government communication links four layers of quality and regulation: (1) Central facilitation for international certification through CDSCO’s Ayush Vertical, (2) third-party quality marks through QCI, (3) healthcare organization accreditation through NABH (National Accreditation Board for Hospitals and Healthcare Providers, described in the communication as a constituent board of QCI), and (4) standard-setting through ISO’s technical committee structures and state-level standardisation bodies.

Related current affairs